Contraceptive Implant Insertion and Removal.
Gilbert BG.
Prim Care. 2021 Dec;48(4):545-554. doi: 10.1016/j.pop.2021.07.002. Epub 2021 Oct 7.
Management of Etonogestrel implant migration into the pulmonary artery.
Clermidy H, Fabre D, Hugues JN, Alonso CG, Mitilian D, Mercier O, Brenot P, Charbonneau P, Fadel E.
Contraception. 2022 Sep;113:62-67. doi: 10.1016/j.contraception.2022.03.017. Epub 2022 Mar 26.
Yutiq - another fluocinolone intravitreal implant for uveitis.
[No authors listed]
Med Lett Drugs Ther. 2021 Jul 26;63(1629):e5-e6.
A mometasone-eluting sinus implant (Sinuva) for nasal polyps.
[No authors listed]
Med Lett Drugs Ther. 2018 Sep 10;60(1555):151-152.
Experience with the Histrelin Implant in Pediatric Patients.
Eugster EA.
Endocr Dev. 2016;30:54-9. doi: 10.1159/000439330. Epub 2015 Dec 10.
Intracrystalline Ozurdex implant: iatrogenic intravitreal injection management.
Cordeiro FM, Botelho DP, Elias Silva LT, Cordeiro BM.
Can J Ophthalmol. 2022 Aug;57(4):e121-e122. doi: 10.1016/j.jcjo.2021.08.009. Epub 2021 Sep 16.
Refillable Intraocular Drug-Eluting Implant.
Kim H, Kang NW, Wise R, Feliz A, Myung D, DeBoer C.
ACS Appl Mater Interfaces. 2025 Jun 11;17(23):33474-33482. doi: 10.1021/acsami.5c03985. Epub 2025 May 7.
Intravitreal slow-releasing dexamethasone implant for idiopathic neuroretinitis.
Çekiç O, Gülkaş S.
Eur J Ophthalmol. 2022 Jan;32(1):NP226-NP229. doi: 10.1177/1120672120953075. Epub 2020 Sep 3.
Polysaccharide-based implant drug delivery systems for precise therapy: Recent developments, and future trends.
Kumar S, Malviya R, Sridhar SB, Wadhwa T, Shareef J, Meenakshi DU.
Ann Pharm Fr. 2025 May;83(3):407-427. doi: 10.1016/j.pharma.2024.12.004. Epub 2024 Dec 13.
Ganciclovir implant in the treatment of cytomegalovirus retinitis.
Chang M, Dunn JP.
Expert Rev Med Devices. 2005 Jul;2(4):421-7. doi: 10.1586/17434440.2.4.421.
